87R5114 SRA-D
 
  By: Oliverson H.B. No. 1164
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the designation of centers of excellence for the
  management and treatment of placenta accreta spectrum disorder.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Chapter 32, Health and Safety Code, is amended by
  adding Subchapter G to read as follows:
  SUBCHAPTER G. CENTERS OF EXCELLENCE FOR MANAGEMENT AND TREATMENT
  OF PLACENTA ACCRETA SPECTRUM DISORDER
         Sec. 32.201.  DEFINITION. In this subchapter, "placenta
  accreta spectrum disorder" includes placenta accreta, placenta
  increta, and placenta percreta.
         Sec. 32.202.  DESIGNATION OF CENTERS OF EXCELLENCE. (a) The
  department, in consultation with the Texas Maternal Mortality and
  Morbidity Review Committee established under Chapter 34, shall
  designate as centers of excellence for the management and treatment
  of placenta accreta spectrum disorder one or more health care
  entities or programs in this state, including any institution or
  community hospital with the appropriate resources and personnel, as
  determined by the department and the review committee.
         (b)  The executive commissioner, in consultation with the
  department and the Texas Maternal Mortality and Morbidity Review
  Committee, shall adopt rules necessary for a health care entity or
  program in this state to be designated as a center of excellence for
  management and treatment of placenta accreta spectrum disorder.
         Sec. 32.203.  SUBCOMMITTEE. (a) The department, in
  consultation with the Texas Maternal Mortality and Morbidity Review
  Committee, shall appoint a subcommittee of the review committee to
  advise the executive commissioner on the adoption of rules under
  Section 32.202. As part of the subcommittee's duties under this
  subsection, the subcommittee specifically shall advise the
  executive commissioner on the criteria necessary for a health care
  entity or program in this state to be awarded a designation under
  this subchapter.
         (b)  The subcommittee must consist of individuals with
  expertise in the management and treatment of placenta accreta
  spectrum disorder. A majority of the members of the subcommittee
  must practice in those areas in a health profession in this state.
  The subcommittee may include national and international experts.
         Sec. 32.204.  PRIORITY CONSIDERATIONS FOR CENTER
  DESIGNATIONS.  The rules adopted under Section 32.202 must
  prioritize awarding a designation under this subchapter to a health
  care entity or program that:
               (1)  offers specialized management services for
  placenta accreta spectrum disorder through a multi-specialty
  clinical program and an associated hospital that provides advanced
  neonatal and maternal care in accordance with the hospital's level
  of care designation assigned under Section 241.182;
               (2)  demonstrates a significant commitment to research
  in and advancing the field of care for placenta accreta spectrum
  disorder;
               (3)  fosters telemedicine, referral, and transport
  relationships with rural hospitals in this state; and
               (4)  integrates an advanced placenta accreta spectrum
  disorder management program with a program that provides
  appropriate long-term monitoring and follow-up care for patients.
         Sec. 32.205.  REQUIREMENTS FOR CENTER DESIGNATION. The
  rules adopted under Section 32.202 must ensure that a health care
  entity or program in this state that receives a center of excellence
  designation under this subchapter:
               (1)  provides or is affiliated with a hospital that
  provides advanced neonatal and maternal care in accordance with the
  hospital's level of care designation assigned under Section
  241.182;
               (2)  establishes minimum criteria for medical,
  nursing, ancillary, and support staff, in addition to any other
  criteria required under Section 32.202;
               (3)  measures short-term and long-term patient
  diagnostic and therapeutic outcomes; and
               (4)  submits to the department annual reports
  containing aggregate data on short-term and long-term diagnostic
  and therapeutic outcomes as requested or required by the department
  and makes those reports available to the public on the entity's or
  program's Internet website.
         SECTION 2.  (a)  Not later than December 1, 2021, the
  Department of State Health Services, in consultation with the Texas
  Maternal Mortality and Morbidity Review Committee established
  under Chapter 34, Health and Safety Code, shall appoint members to
  the subcommittee as required by Section 32.203, Health and Safety
  Code, as added by this Act.
         (b)  Not later than September 1, 2022, the executive
  commissioner of the Health and Human Services Commission shall
  adopt rules as required by Section 32.202, Health and Safety Code,
  as added by this Act.
         (c)  Not later than September 1, 2022, the Department of
  State Health Services shall begin awarding designations of centers
  of excellence as required by Subchapter G, Chapter 32, Health and
  Safety Code, as added by this Act.
         SECTION 3.  This Act takes effect September 1, 2021.